Keratin 9 (KRT9) (C-Term) Peptide
KRT9
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all KRT9 products
- KRT9 (Keratin 9 (KRT9))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- EIELQSQLSK KAALEKSLED TKNRYCGQLQ MIQEQISNLE AQITDVRQEI
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-KRT9 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- KRT9 (Keratin 9 (KRT9))
- Synonyms
- CK-9 Peptide, EPPK Peptide, K9 Peptide, Krt1-9 Peptide, keratin 9 Peptide, KRT9 Peptide, Krt9 Peptide
- Background
-
This gene encodes the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles. Mutations in this gene cause epidermolytic palmoplantar keratoderma.
Alias Symbols: CK-9, EPPK, K9
Protein Size: 623 - Molecular Weight
- 62 kDa
- Gene ID
- 3857
- NCBI Accession
- NM_000226, NP_000217
- UniProt
- P35527
-
You are here:
